28.03.2024 14:35 | GDR, SAAS, AXL | EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate | Alliance |
28.03.2024 07:00 | GDR | Half-year Report | RNS |
26.03.2024 07:00 | GDR | Investor presentation | Reach |
19.03.2024 15:53 | GDR | Application for Listing & Total Voting Rights | RNS |
15.03.2024 13:50 | GDR | Genedrive down as plans equity raise despite GBP800,000 tax credit | Alliance |
15.03.2024 12:30 | GDR | Receipt of R&D tax credit | RNS |
19.02.2024 18:57 | MOS, PHE, CORO | TRADING UPDATES: Coro seals sale terms, Powerhouse makes good progress | Alliance |
19.02.2024 07:00 | GDR | NICE Early Value Assessment update | RNS |
19.01.2024 16:14 | GDR | Total Voting Rights | RNS |
15.01.2024 15:21 | GDR | Total Voting Rights | RNS |
10.01.2024 07:00 | GDR | Total Voting Rights | RNS |
02.01.2024 10:57 | GDR | IN BRIEF: Genedrive draws down GBP600,000 on prepayment facility | Alliance |
02.01.2024 07:00 | GDR | Equity Prepayment Facility drawdown | RNS |
29.12.2023 11:44 | GDR | Result of AGM | RNS |
22.12.2023 15:50 | WBI, TFG, SBTX | UK shareholder meetings calendar - next 7 days | Alliance |
20.12.2023 16:57 | GDR | Total Voting Rights | RNS |
20.12.2023 11:07 | ANGS, GDR, VRS | AIM WINNERS & LOSERS: Genedrive shares jump on orders | Alliance |
20.12.2023 10:49 | GDR | IN BRIEF: Genedrive shares surge as six countries receive first orders | Alliance |
20.12.2023 07:00 | GDR | Initial overseas orders of MT-RNR1 ID kit | RNS |
07.12.2023 07:00 | GDR | Total Voting Rights | RNS |
06.12.2023 07:00 | GDR | Posting of annual report and notice of AGM | RNS |
06.12.2023 07:00 | GDR | Total Voting Rights | RNS |
04.12.2023 17:33 | MSYS, SIXH, AFC | TRADING UPDATES: 600 Group disposal and funding talks continue | Alliance |
04.12.2023 13:13 | GDR | MT-RNR1 ID kit adopted for routine use in Brighton | RNS |
30.11.2023 17:29 | GDR | Block listing Interim Review | RNS |
30.11.2023 10:03 | GDR | Genedrive shares fall as annual loss widens but focused on investing | Alliance |
30.11.2023 07:00 | GDR | Final Results | RNS |
29.11.2023 21:36 | GDR, BMN, AURR | EARNINGS AND TRADING: Southern Energy loss swing; Craven House widens | Alliance |
29.11.2023 17:25 | GDR | Equity Prepayment Facility drawdown | RNS |
23.11.2023 15:54 | ZOO, WCW, THS | UK earnings, trading statements calendar - next 7 days | Alliance |
16.11.2023 07:00 | GDR | Notice of Results | RNS |
20.10.2023 10:52 | GDR | Total Voting Rights | RNS |
28.09.2023 16:09 | GDR | IN BRIEF: Genedrive to receive GBP1.2 million grant for test kit | Alliance |
28.09.2023 12:35 | GDR | c£1.2m grant awarded | RNS |
21.09.2023 14:39 | GDR | Application for listing & total voting rights | RNS |
11.09.2023 15:21 | GDR | Genedrive appoints new chief executive and chief scientific officer | Alliance |
11.09.2023 14:17 | GDR | Board changes | RNS |
06.09.2023 11:18 | GDR | Genedrive shares jump as hails UKCA mark for test; aims for EU CE mark | Alliance |
06.09.2023 07:00 | GDR | UKCA marking achieved for new CYP2C19 test | RNS |
04.08.2023 16:00 | GDR | Total Voting Rights | RNS |
05.07.2023 15:30 | GDR, ZEN, KZG | TRADING UPDATES: RTW plans buyback; Octopus AIM VCTs eye fundraise | Alliance |
05.07.2023 09:11 | GDR | Equity Prepayment Facility drawdown | RNS |
16.06.2023 14:28 | GDR | Holding(s) in Company | RNS |
16.06.2023 10:29 | GDR, VAL, MRL | AIM WINNERS & LOSERS: Marlowe up on report of potential division sale | Alliance |
16.06.2023 09:27 | GDR | IN BRIEF: Genedrive shares up as UK government grant received | Alliance |
16.06.2023 07:00 | GDR | Multi-partner grant awarded | RNS |
02.06.2023 12:25 | GDR | Equity Prepayment Facility drawdown | RNS |
31.05.2023 07:00 | GDR | Block Listing Returns | RNS |
19.05.2023 10:24 | GDR | Genedrive says NICE committee recommends CYP2C19 for stroke patients | Alliance |
19.05.2023 10:15 | GDR | AIM WINNERS & LOSERS: iEnergizer to depart; Unbound for sale | Alliance |
15.05.2023 17:56 | GDR | Block Listing Application to AIM | RNS |
11.05.2023 11:58 | GDR | Result of General Meeting | RNS |
04.05.2023 16:11 | WPS, VID, UPR | UK shareholder meetings calendar - next 7 days | Alliance |
24.04.2023 11:54 | GDR | Publication of Circular and Notice of GM | RNS |
11.04.2023 17:44 | GDR | Holding(s) in Company | RNS |
06.04.2023 08:00 | GDR | Total Voting Rights | RNS |
31.03.2023 20:33 | GDR | IN BRIEF: Genedrive sees acceleration of revenue in 2023 | Alliance |
31.03.2023 18:32 | GDR | £5 million Equity Prepayment Facility | RNS |
31.03.2023 18:32 | GDR | Half-year Report | RNS |
30.03.2023 16:35 | GDR | Price Monitoring Extension | RNS |
30.03.2023 11:18 | GDR | Genedrive MT-RNR1 ID kit receives final UK NICE recommendation for NHS | Alliance |
30.03.2023 09:05 | GDR | Second Price Monitoring Extn | RNS |
30.03.2023 09:00 | GDR | Price Monitoring Extension | RNS |
30.03.2023 07:00 | GDR | Positive final recommendation by NICE | RNS |
23.03.2023 16:35 | GDR | Price Monitoring Extension | RNS |
20.03.2023 09:37 | JLP, GDR, DCTA | AIM WINNERS & LOSERS: Tribal shares drop on NTU contract termination | Alliance |
20.03.2023 09:21 | GDR | Genedrive to roll out hearing loss screening in two NHS sites | Alliance |
20.03.2023 07:00 | GDR | Commence of roll out in Greater Manchester | RNS |
09.02.2023 14:05 | GDR | Second Price Monitoring Extn | RNS |
09.02.2023 14:00 | GDR | Price Monitoring Extension | RNS |
09.02.2023 11:19 | ZYT, BEM, STX | AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages | Alliance |
09.02.2023 10:36 | GDR | Genedrive hearing loss test recommended by UK health department body | Alliance |
09.02.2023 09:05 | GDR | Second Price Monitoring Extn | RNS |
09.02.2023 09:00 | GDR | Price Monitoring Extension | RNS |
09.02.2023 07:00 | GDR | AIHL test preliminary recommendation by NICE | RNS |